Skip to main content
Clinical Trials/CTRI/2023/11/059540
CTRI/2023/11/059540
Recruiting
Phase 4

A Clinical Study to evaluate the 72 hour moisturization potential of Plum Oat & Allantoin All-day Nourishing Cream. - NI

Pureplay skin sciences0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Pureplay skin sciences
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Pureplay skin sciences

Eligibility Criteria

Inclusion Criteria

  • 1\) Gender: Male or Female 18 to 50
  • 2\) Subjects willing to give written informed
  • 3\) Women of child bearing potential must have a negative urine pregnancy test prior to study entry.
  • 4\) Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study
  • results or increase the risk of adverse events.
  • 5\) Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of

Exclusion Criteria

  • 1\. Subjects who are pregnant, breast\-feeding, or planning to become pregnant during the study.
  • 2\. Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
  • 3\. Have open sores or open lesions in the treatment area(s).
  • 4\. Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product.
  • 5\. Have participated in any interventional clinical trial in the previous 90 days.
  • 6\. Have a known sensitivity to any of the constituents of the test product including sensitivities to Helianthus Annuus, Avena Sativa (Oat) Kernel, Argania Spinosa.
  • 7\. Have used, are using, or are planning to use
  • immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.
  • 8\. Have not skin related issues

Outcomes

Primary Outcomes

Not specified

Similar Trials